Our Resources

ObvioHealth highlight the benefits of incorporating DCTs, as well as the challenges associated with DCTs, and call out specific use cases for DCTs.

ObvioHealth announces it has been rated as the top “major contender” on Everest Group’s 2022 PEAK Matrix®, an industry report providing analysis and insights on decentralized clinical trial vendors. ObvioHealth is ranked 5th overall in a field of 24 industry players.

ObvioHealth, a global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trials (DCT), is collaborating with Oracle in Asia Pacific to help get breakthrough therapies to market faster through more efficient integration of diverse data sets. The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.

We know that a patient-centric approach to clinical trials generally leads to higher compliance and retention rates. DCTs are more convenient for participants.

In the first of our two-part series exploring minority participation in clinical trial research, we examine the numerous challenges to securing diversity in clinical trials and the consequences of primarily white patient populations.

ObvioHealth, a global virtual research organization (VRO), announces the launch of its cutting-edge patient engagement suite, designed to motivate and support decentralized clinical trial patients from the moment of recruitment through study completion. These patient-centric products and services, deployed through ObvioHealth’s powerful ObvioGo platform and app, significantly increase clinical trial compliance and retention while also delivering more accurate and real-time data.

ObvioHealth tackles misconceptions about decentralized clinical trials, they’re less safe, they’re always fully virtual, the data isn’t trustworthy, and so on.

ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo, a next-generation decentralized clinical trial platform and mobile application powered to deliver stronger evidence of therapeutic efficacy and safety.